Promoter occupancy of MLL1 histone methyltransferase seems to specify the proliferative and apoptotic functions of E2F1 in a tumour microenvironment

Journal of Cell Science

Volumn 126, Issue 20, 2013, Pages 4636-4646

  Swarnalatha, Manickavinayaham ^a   Singh, Anup Kumar ^a   Kumar, Vijay ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Apoptosis; DNA damage; E2F1; HBx; MLL1; Replication stress; X15 myc mice

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE MIXED LINEAGE LEUKEMIA 1 PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL CYCLE REGULATION; CELL DIVISION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DEATH; DNA DAMAGE; HEPATITIS B VIRUS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; TUMOR MICROENVIRONMENT;

APOPTOSIS; DNA DAMAGE; E2F1; HBX; MLL1; REPLICATION STRESS; X15-MYC MICE;

ANIMALS; APOPTOSIS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA DAMAGE; E2F1 TRANSCRIPTION FACTOR; HEP G2 CELLS; HEPATOBLASTOMA; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROMOTER REGIONS, GENETIC; TUMOR MICROENVIRONMENT; UBIQUITINATION;

EID: 84885442329     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.126235     Document Type: Article

References (59)

1. Attwooll, C., Lazzerini Denchi, E. and Helin, K. (2004). The E2F family: specific functions and overlapping interests. EMBO J. 23, 4709-4716.
2. Baresova, P., Pitha, P. M. and Lubyova, B. (2012). Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c- Myc protein function and stability. J. Biol. Chem. 287, 16199-16208.
3. Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L. and Vousden, K. H. (1998). p14ARF links the tumour suppressors RB and p53. Nature 395, 124-125.
4. Biswas, A. K. and Johnson, D. G. (2012). Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. Cancer Res. 72, 13-17.
5. Blais, A. and Dynlacht, B. D. (2007). E2F-associated chromatin modifiers and cell cycle control. Curr. Opin. Cell Biol. 19, 658-662.
6. Budhavarapu, V. N., White, E. D., Mahanic, C. S., Chen, L., Lin, F. T. and Lin, W. C. (2012). Regulation of E2F1 by APC/C Cdh1 via K11 linkage-specific ubiquitin chain formation. Cell Cycle 11, 2030-2038.
7. Burhans, W. C. and Weinberger, M. (2007). DNA replication stress, genome instability and aging. Nucleic Acids Res. 35, 7545-7556.
8. Cam, H. and Dynlacht, B. D. (2003). Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 3, 311-316.
9. Campanero, M. R. and Flemington, E. K. (1997). Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94, 2221-2226.
10. Chaurushiya, M. S. and Weitzman, M. D. (2009). Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair (Amst.) 8, 1166-1176.
11. Chen, H. Z., Tsai, S. Y. and Leone, G. (2009). Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat. Rev. Cancer 9, 785-797.
12. Cougot, D., Wu, Y., Cairo, S., Caramel, J., Renard, C. A., Lévy, L., Buendia, M. A. and Neuveut, C. (2007). The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J. Biol. Chem. 282, 4277-4287.
13. DeGregori, J. and Johnson, D. G. (2006). Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. Curr. Mol. Med. 6, 739-748.
14. DeGregori, J., Kowalik, T. and Nevins, J. R. (1995). Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15, 4215-4224.
15. Dimova, D. K. and Dyson, N. J. (2005). The E2F transcriptional network: old acquaintances with new faces. Oncogene 24, 2810-2826.
16. Engelmann, D. and Pützer, B. M. (2010). Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance. Drug Resist. Updat. 13, 119-131.
17. Ernst, P., Wang, J., Huang, M., Goodman, R. H. and Korsmeyer, S. J. (2001). MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol. Cell. Biol. 21, 2249-2258.
18. Evan, G. I. and Vousden, K. H. (2001). Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348.
19. Guenther, M. G., Levine, S. S., Boyer, L. A., Jaenisch, R. and Young, R. A. (2007). A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130, 77-88.
20. Guo, R., Chen, J., Mitchell, D. L. and Johnson, D. G. (2011). GCN5 and E2F1 stimulate nucleotide excision repair by promoting H3K9 acetylation at sites of damage. Nucleic Acids Res. 39, 1390-1397.
21. Hallstrom, T. C. and Nevins, J. R. (2009). Balancing the decision of cell proliferation and cell fate. Cell Cycle 8, 532-535.
22. Hofmann, F., Martelli, F., Livingston, D. M. and Wang, Z. (1996). The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitinproteasome pathway. Genes Dev. 10, 2949-2959.
23. Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K. and Lu, X. (1997). E2F1- induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11, 1840-1852.
24. Hung, L. and Kumar, V. (2004). Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs. FEBS Lett. 560, 210-214.
25. Johnson, D. G. (2000). The paradox of E2F1: oncogene and tumor suppressor gene. Mol. Carcinog. 27, 151-157.
26. Johnson, D. G. and Degregori, J. (2006). Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context. Curr. Mol. Med. 6, 731-738.
27. Jung, J. K., Arora, P., Pagano, J. S. and Jang, K. L. (2007). Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 67, 5771-5778.
28. Kalra, N. and Kumar, V. (2006). The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc. FEBS Lett. 580, 431-436.
29. Khattar, E., Mukherji, A. and Kumar, V. (2012). Akt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylation. FEBS J. 279, 1220-1230.
30. Krivtsov, A. V. and Armstrong, S. A. (2007). MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 7, 823- 833.
31. Kumar, V., Jayasuryan, N. and Kumar, R. (1996). A truncated mutant (residues 58- 140) of the hepatitis B virus X protein retains transactivation function. Proc. Natl. Acad. Sci. USA 93, 5647-5652.
32. Lakhtakia, R., Kumar, V., Reddi, H., Mathur, M., Dattagupta, S. and Panda, S. K. (2003). Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: A sequential pathological evaluation. J. Gastroenterol. Hepatol. 18, 80-91.
33. Liu, K., Luo, Y., Lin, F. T. and Lin, W. C. (2004). TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival. Genes Dev. 18, 673-686.
34. Liu, H., Cheng, E. H. and Hsieh, J. J. (2007). Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions. Genes Dev. 21, 2385-2398.
35. Martelli, F., Hamilton, T., Silver, D. P., Sharpless, N. E., Bardeesy, N., Rokas, M., DePinho, R. A., Livingston, D. M. and Grossman, S. R. (2001). p19ARF targets certain E2F species for degradation. Proc. Natl. Acad. Sci. USA 98, 4455-4460.
36. Marti, A., Wirbelauer, C., Scheffner, M. and Krek, W. (1999). Interaction between ubiquitin-protein ligase SCFSkp2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat. Cell Biol. 1, 14-19.
37. Méndez, J., Zou-Yang, X. H., Kim, S. Y., Hidaka, M., Tansey, W. P. and Stillman, B. (2002). Human origin recognition complex large subunit is degraded by ubiquitinmediated proteolysis after initiation of DNA replication. Mol. Cell 9, 481-491.
38. Molina-Jiménez, F., Benedicto, I., Murata, M., Martín-Vílchez, S., Seki, T., Antonio Pintor-Toro, J., Tortolero, M., Moreno-Otero, R., Okazaki, K., Koike, K. et al. (2010). Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation. Hepatology 51, 777-787.
39. Moroni, M. C., Hickman, E. S., Lazzerini Denchi, E., Caprara, G., Colli, E., Cecconi, F., Müller, H. and Helin, K. (2001). Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3, 552-558.
40. Mukherji, A., Janbandhu, V. C. and Kumar, V. (2007). HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1. Biochem. J. 401, 247-256.
41. Nahle, Z., Polakoff, J., Davuluri, R. V., McCurrach, M. E., Jacobson, M. D., Narita, M., Zhang, M. Q., Lazebnik, Y., Bar-Sagi, D. and Lowe, S. W. (2002). Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4, 859- 864.
42. Peart, M. J., Poyurovsky, M. V., Kass, E. M., Urist, M., Verschuren, E. W., Summers, M. K., Jackson, P. K. and Prives, C. (2010). APC/C(Cdc20) targets E2F1 for degradation in prometaphase. Cell Cycle 9, 3956-3964.
43. Polager, S. and Ginsberg, D. (2008). E2F - at the crossroads of life and death. Trends Cell Biol. 18, 528-535.
44. Polager, S. and Ginsberg, D. (2009). p53 and E2f: partners in life and death. Nat. Rev. Cancer 9, 738-748.
45. Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S. and Bonner, W. M. (1998). DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868.
46. Rogoff, H. A. and Kowalik, T. F. (2004). Life, death and E2F: linking proliferation control and DNA damage signaling via E2F1. Cell Cycle 3, 843-844.
47. Saunders, N. A., Dicker, A. J., Jones, S. J. and Dahler, A. L. (1998). E2F1 messenger RNA is destabilized in response to a growth inhibitor in normal human keratinocytes but not in a squamous carcinoma cell line. Cancer Res. 58, 1646-1649.
48. Singh, A. K., Swarnalatha, M. and Kumar, V. (2011). c-ETS1 facilitates G1/S-phase transition by up-regulating cyclin E and CDK2 genes and cooperates with hepatitis B virus X protein for their deregulation. J. Biol. Chem. 286, 21961-21970.
49. Taylor, R. C., Cullen, S. P. and Martin, S. J. (2008). Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9, 231-241.
50. Trouche, D., Cook, A. and Kouzarides, T. (1996). The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res. 24, 4139-4145.
51. Tyagi, S., Chabes, A. L., Wysocka, J. and Herr, W. (2007). E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol. Cell 27, 107-119.
52. Urist, M., Tanaka, T., Poyurovsky, M. V. and Prives, C. (2004). p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev. 18, 3041-3054.
53. Weinmann, A. S. and Farnham, P. J. (2002). Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 26, 37-47.
54. Wilson, A. C. (2007). Setting the stage for S phase. Mol. Cell 27, 176-177.
55. Wu, P. Y. and Nurse, P. (2009). Establishing the program of origin firing during S phase in fission Yeast. Cell 136, 852-864.
56. Wu, L., Timmers, C., Maiti, B., Saavedra, H. I., Sang, L., Chong, G. T., Nuckolls, F., Giangrande, P., Wright, F. A., Field, S. J. et al. (2001). The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414, 457-462.
57. Wu, Z., Zheng, S. and Yu, Q. (2009). The E2F family and the role of E2F1 in apoptosis. Int. J. Biochem. Cell Biol. 41, 2389-2397.
58. Wysocka, J., Swigut, T., Milne, T. A., Dou, Y., Zhang, X., Burlingame, A. L., Roeder, R. G., Brivanlou, A. H. and Allis, C. D. (2005). WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 121, 859-872.
59. Zhivotovsky, B. and Kroemer, G. (2004). Apoptosis and genomic instability. Nat. Rev. Mol. Cell Biol. 5, 752-762.